Showing results 17 to 19 of 19
Issue Date | Title | Author(s) |
---|---|---|
2022-09 | Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast Cancers | Kuchukulla, Ratnakar Reddy; Hwang, Injeoung; Park, Sang Won; Moon, Sojeong; Kim, Suhn Hyung; Kim, Sumin; Chung, Hwan Won; Ji, Mi-Jung; Park, Hyun-Mee; Kong, Gu; Hur, Wooyoung |
2014-12-19 | Patient-derived models of acquired resistance can identify effective drug combinations for cancer | Crystal, Adam S.; Shaw, Alice T.; Sequist, Lecia V.; Friboulet, Luc; Niederst, Matthew J.; Lockerman, Elizabeth L.; Frias, Rosa L.; Gainor, Justin F.; Amzallag, Arnaud; Greninger, Patricia; Lee, Dana; Kalsy, Anuj; Gomez-Caraballo, Maria; Elamine, Leila; Howe, Emily; Hur, Wooyoung; Lifshits, Eugene; Robinson, Hayley E.; Katayama, Ryohei; Faber, Anthony C.; Awad, Mark M.; Ramaswamy, Sridhar; Mino-Kenudson, Mari; Iafrate, A. John; Benes, Cyril H.; Engelman, Jeffrey A. |
2019-11 | Virtual screening of Mao-B inhibitors using generative deep learning and target focused statistical potential | Chung, Hwan Won; ROH, EUN JOO; Hur, Wooyoung |